Amiloride and Gastric Cancer in Rats
Author Information
Author(s): M. Tatsuta, H. Jishi, M. Baba, H. Uehara, A. Nakaizumi, H. Taniguchi
Primary Institution: The Center for Adult Diseases, Osaka
Hypothesis
Does amiloride inhibit gastric carcinogenesis induced by N-methyl-N'-nitro-N-nitrosoguanidine in Wistar rats?
Conclusion
Amiloride significantly decreases the incidence of gastric cancers in Wistar rats without affecting their histological features.
Supporting Evidence
- Prolonged administration of amiloride significantly decreased the incidence of gastric cancers.
- Amiloride did not influence the histological features of the gastric cancers.
- Amiloride significantly decreased the labelling index and proliferative fraction of the antral mucosa.
Takeaway
Amiloride, a diuretic drug, helps prevent stomach cancer in rats by slowing down the growth of stomach cells.
Methodology
Wistar rats were treated with a carcinogen and then given amiloride injections to assess its effects on cancer incidence and cell proliferation.
Limitations
The study only involved male Wistar rats, which may limit the generalizability of the findings.
Participant Demographics
75 male Wistar rats, 6 weeks old.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website